C. Onal Et Al. , "Stereotactic radiotherapy to oligoprogressive lesions detected with 68Ga-PSMA-PET/CT in castration-resistant prostate cancer patients.," European journal of nuclear medicine and molecular imaging , vol.48, no.11, pp.3683-3692, 2021
Onal, C. Et Al. 2021. Stereotactic radiotherapy to oligoprogressive lesions detected with 68Ga-PSMA-PET/CT in castration-resistant prostate cancer patients.. European journal of nuclear medicine and molecular imaging , vol.48, no.11 , 3683-3692.
Onal, C., Ozyigit, G., Oymak, E., Guler, O. C., Tilki, B., Hurmuz, P., ... Akyol, F.(2021). Stereotactic radiotherapy to oligoprogressive lesions detected with 68Ga-PSMA-PET/CT in castration-resistant prostate cancer patients.. European journal of nuclear medicine and molecular imaging , vol.48, no.11, 3683-3692.
Onal, Cem Et Al. "Stereotactic radiotherapy to oligoprogressive lesions detected with 68Ga-PSMA-PET/CT in castration-resistant prostate cancer patients.," European journal of nuclear medicine and molecular imaging , vol.48, no.11, 3683-3692, 2021
Onal, Cem Et Al. "Stereotactic radiotherapy to oligoprogressive lesions detected with 68Ga-PSMA-PET/CT in castration-resistant prostate cancer patients.." European journal of nuclear medicine and molecular imaging , vol.48, no.11, pp.3683-3692, 2021
Onal, C. Et Al. (2021) . "Stereotactic radiotherapy to oligoprogressive lesions detected with 68Ga-PSMA-PET/CT in castration-resistant prostate cancer patients.." European journal of nuclear medicine and molecular imaging , vol.48, no.11, pp.3683-3692.
@article{article, author={Cem Onal Et Al. }, title={Stereotactic radiotherapy to oligoprogressive lesions detected with 68Ga-PSMA-PET/CT in castration-resistant prostate cancer patients.}, journal={European journal of nuclear medicine and molecular imaging}, year=2021, pages={3683-3692} }